| Literature DB >> 26034997 |
Pradip Kumar Kamat1,1, Anuradha Kalani1,1, Naira Metreveli1,1, Suresh C Tyagi1,1, Neetu Tyagi1,1.
Abstract
Ischemic brain stroke is a leading cause of disability and includes hearing loss. Clinical reports have also suggested that there is hearing loss in stroke patients but the mechanism was not determined. Therefore, we hypothesized that hearing loss after cerebral ischemia may be associated with changes to the synapse, gap junction, and sodium channel (NaC) proteins. Ischemia-reperfusion injury was induced in wild-type mice (I/R group). The lesion volume was determined by 2,3,5-triphenyltetrazolium chloride (TTC) staining of the brain sections. BBB disruption was confirmed by Evans blue staining and leakage of bovine serum albumin labeled with fluorescein isothiocyanate (BSA-FITC). We found that brain edema, infarct size, and permeability were increased in ischemic mice as compared with the sham-operated group. Caspase-3, caspase-9, and TUNEL-positive cells were increased in I/R mice, indicating neuronal apoptosis. Moreover, there were increased expressions of matrix metalloprotease's (MMP-2, -3, -9, and -13), interleukin (IL)-6, and decreased expressions of tight junction proteins (TJP) in the I/R group, as compared with the sham group, which signifies inflammation and BBB disruption. We also observed decreased levels of post-synaptic density protein-95 (PSD-95), synapse-associated protein 97 (SAP-97), connexin-43, NaC-α, and NaC-β, and increased expression of connexin-45, whereas no substantial change was observed in connexin-26 expression in the I/R group. Interestingly, auditory response was reduced in the I/R mice, indicating hearing loss. These data suggest that hearing loss in ischemic mice was primarily due to alterations in connexin, synapses, and NaC channels.Entities:
Keywords: apoptose; apoptosis; barrière hémo–encéphalique; blood–brain barrier; cerebral ischemia; hearing loss; ischémie cérébrale; neurotransmission; perte auditive
Mesh:
Substances:
Year: 2015 PMID: 26034997 PMCID: PMC4567529 DOI: 10.1139/cjpp-2014-0489
Source DB: PubMed Journal: Can J Physiol Pharmacol ISSN: 0008-4212 Impact factor: 2.273